ONCONOVA THERAPEUTICS INC's ticker is ONTX and the CUSIP is 68232V405. A total of 31 filers reported holding ONCONOVA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $251,000 | +114.5% | 250,847 | 0.0% | 0.15% | +96.2% |
| Q4 2020 | $117,000 | +67.1% | 250,847 | 0.0% | 0.08% | +56.0% |
| Q3 2020 | $70,000 | -50.7% | 250,847 | 0.0% | 0.05% | -59.3% |
| Q2 2020 | $142,000 | +86.8% | 250,847 | 0.0% | 0.12% | +61.8% |
| Q1 2020 | $76,000 | -20.8% | 250,847 | 0.0% | 0.08% | -5.0% |
| Q4 2019 | $96,000 | – | 250,847 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYNDALL CAPITAL PARTNERS L P | 816,272 | $5,991,000 | 75.56% |
| 683 Capital Management, LLC | 966,877 | $7,097,000 | 0.46% |
| EcoR1 Capital, LLC | 500,000 | $3,670,000 | 0.33% |
| Kepos Capital LP | 200,000 | $1,468,000 | 0.08% |
| ARMISTICE CAPITAL, LLC | 111,216 | $816,000 | 0.05% |
| Point72 Asset Management, L.P. | 241,850 | $1,775,000 | 0.01% |
| PANAGORA ASSET MANAGEMENT INC | 6,609 | $49,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 26,137 | $191,000 | 0.00% |
| BlackRock Inc. | 42 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 1 | $0 | 0.00% |